XML 15 R2.htm IDEA: XBRL DOCUMENT v3.22.2
CONSOLIDATED BALANCE SHEETS (UNAUDITED) - USD ($)
$ in Millions
Jun. 30, 2022
Dec. 31, 2021
ASSETS:    
Cash and due from banks $ 1,456 $ 1,155
Interest-bearing cash and due from banks 5,058 8,003
Interest-bearing deposits in banks 469 316
Debt securities available for sale, at fair value (including $328 and $640 pledged to creditors, respectively) [1] 24,961 26,067
Debt securities held to maturity (fair value of $9,361 and $2,289 respectively, and including $680 and $77 pledged to creditors, respectively) [1] 9,567 2,242
Loans held for sale, at fair value 1,377 2,733
Other loans held for sale 2,078 735
Loans and leases 156,172 128,163
Less: Allowance for loan and lease losses (1,964) (1,758)
Net loans and leases 154,208 126,405
Derivative assets 1,669 1,216
Premises and equipment, net 885 768
Bank-owned life insurance 3,207 2,843
Goodwill 8,081 7,116
Other assets 13,696 8,810
TOTAL ASSETS 226,712 188,409
Deposits:    
Noninterest-bearing 54,169 49,443
Interest-bearing 124,756 104,918
Total deposits 178,925 154,361
Short-term borrowed funds 3,763 74
Derivative liabilities 1,004 197
Long-term borrowed funds 14,440 6,932
Other liabilities 4,252 3,425
TOTAL LIABILITIES 202,384 164,989
Commitments and Contingencies (refer to Note 13)
Preferred stock:    
$25.00 par value,100,000,000 shares authorized; 2,050,000 shares issued and outstanding at June 30, 2022 and December 31, 2021 2,014 2,014
Common stock:    
$0.01 par value, 1,000,000,000 shares authorized; 644,827,702 shares issued and 495,650,259 shares outstanding at June 30, 2022 and 571,259,135 shares issued and 422,137,197 shares outstanding at December 31, 2021 6 6
Additional paid-in capital 22,100 19,005
Retained earnings 8,346 7,978
Treasury stock, at cost, 149,177,443 and 149,121,938 shares at June 30, 2022 and December 31, 2021, respectively (4,920) (4,918)
Accumulated other comprehensive income (loss) (3,218) (665)
TOTAL STOCKHOLDERS’ EQUITY 24,328 23,420
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY $ 226,712 $ 188,409
[1] Includes only collateral pledged by the Company where counterparties have the right to sell or pledge the collateral.